The Journal of Pharmaceutical Investigation announced a January 2027 special issue focused on translational advances in pharmaceutical dosage form development, centered on particle engineering and formulation science. The call invites work designed to bridge lab-scale successes into manufacturable, clinically viable drug products. For development teams, the theme points toward tighter integration of particle design, solid-state control, analytical characterization, and manufacturing feasibility earlier in the candidate lifecycle—an increasingly emphasized constraint in modern modality expansion.